Literature DB >> 3902300

Implications of tumor progression on clinical oncology.

D R Welch, S P Tomasovic.   

Abstract

Entities:  

Mesh：

Year:  1985        PMID： 3902300     DOI： 10.1007/bf01786761

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN： 0262-0898            Impact factor:   5.150


× No keyword cloud information.
  181 in total

1.  Cell cycle dependency of metastatic lung colony formation.

Authors:  N Suzuki; M Frapart; D J Grdina; M L Meistrich; H R Withers
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

2.  Selection of successive tumour lines for metastasis.

Authors:  I J Fidler
Journal:  Nat New Biol       Date:  1973-04-04

3.  Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to adriamycin, 5-fluoro-2'-deoxyuridine and methotrexate treatment in vitro.

Authors:  D R Welch; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1983 Oct-Dec       Impact factor: 5.150

4.  Heterogeneous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma.

Authors:  P W Vaupel; S Frinak; H I Bicher
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

5.  Effect of serial passage in nude athymic mice on the growth characteristics and chemotherapy responsiveness of 13762 and R3230AC mammary tumor xenografts.

Authors:  A E Bogden; D E Kelton; W R Cobb; T A Gulkin; R K Johnson
Journal:  Cancer Res       Date:  1978-01       Impact factor: 12.701

6.  Selection and biologic properties of malignant variants of a murine lymphosarcoma.

Authors:  K W Brunson; G L Nicolson
Journal:  J Natl Cancer Inst       Date:  1978-12       Impact factor: 13.506

7.  Variant generation and selection: an in vitro model of tumor progression.

Authors:  D A Chow
Journal:  Int J Cancer       Date:  1984-04-15       Impact factor: 7.396

8.  Altered tumor growth in vivo after immunization of mice with antitumor antibodies.

Authors:  R M Gorczynski; M Kennedy; I Polidoulis; G B Price
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

Review 9.  Tumor cell diversity and host responses in cancer metastasis--part II--host immune responses and therapy of metastases.

Authors:  G L Nicolson; G Poste
Journal:  Curr Probl Cancer       Date:  1983-01       Impact factor: 3.187

10.  Acquisition of high metastatic capacity after in vitro fusion of a nonmetastatic tumor line with a bone marrow-derived macrophage.

Authors:  L Larizza; V Schirrmacher; E Pflüger
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307
View more
  22 in total

1.  Analysis of mechanisms underlying BRMS1 suppression of metastasis.

Authors:  R S Samant; M J Seraj; M M Saunders; T S Sakamaki; L A Shevde; J F Harms; T O Leonard; S F Goldberg; L Budgeon; W J Meehan; C R Winter; N D Christensen; M F Verderame; H J Donahue; D R Welch
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 2.  AACR centennial series: the biology of cancer metastasis: historical perspective.

Authors:  James E Talmadge; Isaiah J Fidler
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

3.  Tumor Heterogeneity--A 'Contemporary Concept' Founded on Historical Insights and Predictions.

Authors:  Danny R Welch
Journal:  Cancer Res       Date:  2016-01-03       Impact factor: 12.701

Review 4.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

5.  Proton NMR examination of tumor cells of high or low metastatic potential.

Authors:  S D Bines; S P Tomasovic; J W Frazer; J Leveque; A W Boddie; L Dennis
Journal:  Clin Exp Metastasis       Date:  1987-09       Impact factor: 5.150

6.  Effect of hyperthermia and thermochemotherapy on primary and metastatic tumour cells of AKR lymphoma.

Authors:  G Klorin; A Siegal; B Bar-Shira-Maymon; O Klein; J Leibovici
Journal:  Int J Exp Pathol       Date:  1990-08       Impact factor: 1.925

Review 7.  Defining the Hallmarks of Metastasis.

Authors:  Danny R Welch; Douglas R Hurst
Journal:  Cancer Res       Date:  2019-05-03       Impact factor: 12.701

8.  Growth, morphologic, and invasive characteristics of early and late passages of a human endometrial carcinoma cell line (RL95-2).

Authors:  P Sundareshan; M J Hendrix
Journal:  In Vitro Cell Dev Biol       Date:  1992 Jul-Aug

Review 9.  Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potential.

Authors:  Brigid S Mumford; Gavin P Robertson
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

10.  Sensitivity to thermochemotherapy of AKR lymphoma and B16 melanoma variants of malignancy.

Authors:  J Leibovici; G Klorin; M Huszar; S Hoenig; O Klein; M Michowitz; A Pinchassov
Journal:  Clin Exp Metastasis       Date:  1990 Jan-Feb       Impact factor: 5.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.